The ISSCR is dedicated to improving human health worldwide by advancing stem cell research and regenerative medicine. We are committed to supporting diversity and inclusion and promoting our entire community, which will also accelerate scientific advancement and allow all people to realize the benefits of stem cell research. During this panel discussion, leading scientists will discuss how to promote equity in STEM, support scientists from historically underrepresented groups, and identify systemic changes that we can advocate for that will promote anti-racism in the field of stem cell science. This panel is sponsored by Synthego.
Melissa Little, PhD
Murdoch Children's Research Institute and University of Melbourne, Australia
Melissa Little is President Elect of the ISSCR. The ISSCR is committed to enhancing diversity, equity, and inclusion in the Society and the stem cell community. We look forward to working together to help ensure we actively take steps to create a more diverse and inclusive Society.
Cato T Laurencin, MD, PhD
The University of Connecticut, USA
Cato T Laurencin has written extensively on the systemic changes necessary to bring racial equity to science and medicine. He will speak about his vision of diversity in a learning and growing environment dedicated to combating racism and his new concept of Inclusion, Diversity, Equity, Anti-racism and Learning (IDEAL).
Shirley Malcom, PhD
American Association for the Advancement of Science, USA
Shirley Malcom is the Director of the STEMM Equity Achievement (SEA Change) Program at the American Association for the Advancement of Science, where she works to transform educational institutions in support of diversity, equity, and inclusion. In her more than 40-year tenure at the Association she has worked to improve the quality and increase access to education and careers in STEM as well as to enhance public science literacy.
Ubaka Ogbogu, LLB, BL, LLM, SJD
University of Alberta, Canada
Ubaka Ogbogu works on the ethical, legal, and societal implications of novel and emerging biotechnologies and the need for equity and anti-racist policies in healthcare. He brings this perspective to his work on the Taskforce to update the ISSCR Guidelines for Stem Cell Research and Clinical Translation.